Eric Lander talks CRISPR and the infamous Nobel ‘rule of three’
By Joel Achenbach,
The Washington Post
| 04. 21. 2016
Untitled Document
“Funny tensions in science.” That’s a phrase from the lips of Eric Lander, president and founding director of the Broad Institute of MIT and Harvard.
He was in Washington earlier this week to appear at the Aspen Institute in conversation with journalist/biographer Walter Isaacson, and inevitably the talk turned to CRISPR, the revolutionary gene-editing technique, and to Lander’s controversial essay earlier this year in the journal Cell, “The Heroes of CRISPR.” The scientific community's reaction highlighted the aforementioned funny tensions; as my colleague Carolyn Johnson reported, Lander's review of the history of CRISPR set off an epic social-media kerfuffle.
In the essay, Lander distributed credit widely for the CRISPR discovery – which rankled some parties who thought they deserved more attention, or felt that Lander had overemphasized the contribution of one of his Broad Institute colleagues. He described CRISPR as the result of many converging innovations, rather than as something that erupted in a classic Eureka! moment. (In this sense, CRISPR is like the computer; as my friend Walter's book "The Innovators" points out, no single person...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...